N-(3,4-dimethoxyphenethyl)-4-(6,7-dimeth
β
Amit S. Kalgutkar; Kosea S. Frederick; Jonathan Chupka; Bo Feng; Sarah Kempshall
π
Article
π
2009
π
John Wiley and Sons
π
English
β 193 KB
The utility of the diaminoquinazoline derivative CP-100,356 as an in vivo probe to selectively assess MDR1/BCRP-mediated drug efflux was examined in the rat. CP-100,356 was devoid of inhibition (IC 50 >50 mM) against major human P450 enzymes including P4503A4. In human MDR1-transfected MDCKII cells,